Protein Potential LLC Awarded $3 Million U.S. NIH Phase II Small Business Innovation Research Grant to Develop a Vaccine Targeting Plasmodium vivax, a Neglected Cause of Malaria

ROCKVILLE, Maryland, April 19, 2010 – Protein Potential LLC has received support from the National Institute of
Allergy and Infectious Diseases (NIAID) of the NIH in the form of a Phase II
Small Business Innovation Research (SBIR) Grant. The three-year award
totaling approximately US$3 million will support translational research to
develop a vaccine for the prevention of malaria [...]

The Astellas European Foundation Winner of Urology 2010 Prize Fund Announced

BARCELONA, Spain, April 19, 2010 – The Astellas European Foundation is delighted to announce the winner of
the 2010 Urology Prize Fund:

Professor Jenny Southgate and Dr Simon Baker from the University of York,
UK
Professor Southgate and Dr Baker received the prize fund of US$ 300,000
to support work on [...]

Teva UK Limited Welcomes DH Consultation on COPD Strategy

CASTLEFORD, England, April 19, 2010 – Teva UK Limited has welcomed the Department of Health's (DH) consultation
on a Strategy for Services for Chronic Obstructive Pulmonary Disease (COPD).

As well as outlining a strategy for COPD services, the document also
incorporates a strategy for asthma management.
Says Robyn Hughes, Director [...]

What Colour is Your Underwear?

BRADFORD ON AVON, England, April 19, 2010 – Think Training & Development believe that the quality of your
life depends upon the quality of the questions you ask yourself.

Don't worry. They don't actually want to know what colour your
underwear is. Especially if it's grey. The point is, when you saw the
question [...]

Immense Opportunities in Store for the Economically Significant Healthcare Industry in Europe, Finds Frost & Sullivan

LONDON, April 19, 2010 – Healthcare has always been an area of utmost importance. It has
significant economic relevance and has been allocated a higher percent of
gross domestic product (GDP) in many countries compared to most other sectors
such as transport and communication, construction and education. Healthcare
also has a huge impact on employment, for the fact [...]

Wake Up to Nocturia

Studies Reinforce Serious Associated Risk of Nocturia
BARCELONA, Spain, April 19, 2010 – Study results discussed today at the European Association of
Urology (EAU) Congress in Barcelona have reinforced the association between
nocturia and a greater risk of falls and mortality.

In a population-representative study in Japan by Nakagawa et
al , it was concluded [...]

Health Robotics Canada Quickly Becomes Largest American I.V. Robotics Company with 15 Contracts in First 3 Months

BOZEN, Sud-Tirol, Italy, April 19, 2010 – Health Robotics today announced the outstanding results reported by one
of its American partners, Health Robotics Canada Inc. (HRCI) first trimester
of operations since its inception in December 2009. These impressive results
included new contracts in North America for seven i.v.STATION, six i.v.SOFT,
one CytoCare, and one I.V. Room of the [...]

Celtic Pharma Announces Preclinical Findings that XERECEPT(R) Potentiates Significantly the Tumor Inhibition Activity of Avastin(R)

NEW YORK, LONDON and BERMUDA, April 19, 2010 – Celtic Pharmaceutical Holdings L.P. ("Celtic Pharma") today
reported at the AACR 101st Annual Meeting 2010 in Washington, DC the results
from several preclinical studies of XERECEPT(R) in established models for
breast, colon and brain tumors. These animal studies were conducted at Duke
University and the Piedmont Research Center using [...]

MarketsandMarkets: BRIC Diabetes Drugs Market Worth US$8.7 Billion By 2014

DALLAS, Texas, April 20, 2010 – The report on BRIC Diabetes Drugs Market
(www.marketsandmarkets.com/Market-Reports/bric-diabetes-199.html)
analyzes the market for oral drugs and injectables in BRIC economies over the
period 2009 to 2014. The report measures and forecasts the BRIC market for
diabetes drugs; and analyzes the major market drivers, restraints, and
opportunities.

Browse more than 15 market [...]

Pipeline Insight: Small Molecule Targeted Cancer Therapies – New Targets Set to Drive Growth Now Available on ReportsandReports

ReportsandReports Announce it Will Carry Pipeline Insight: Small Molecule Targeted Cancer Therapies – New targets set to drive growth Market Research Report in its Store.

DALLAS, April 20, 2010 – Browse the complete Report on:
www.reportsandreports.com/market-reports/pipeline-insight-small-molecu
le-targeted-cancer-therapies-new-/
(Due to the length of this URL, it may be necessary to copy and paste
this hyperlink into [...]

Government Initiatives to Encourage Adoption of Healthcare IT Solutions in Poland, Finds Frost & Sullivan

LONDON, April 20, 2010 – Various initiatives by the Polish Government, coupled with funding from
the European Union (EU), have been driving the adoption of IT systems by the
healthcare sector. The acceptance of the Euro as Poland's currency is set to
further fuel IT funding by the EU in the country.

(Logo: www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)
[...]

CPM Resource Center Selected as Clinical Content Provider for Patient Care Planning at Froedtert & Community Health

CPMRC Content and Transformation Process to Help Wisconsin-based Health System Standardize Care and Support Collaboration, Care Documentation and Evidenced-Based Practice

GRAND RAPIDS, Michigan, April 20, 2010 – The CPM Resource Center (CPMRC) (www.cpmrc.com/), an Elsevier
(www.elsevier.com/wps/find/homepage.cws_home) company and leader in
developing clinical practice guidelines for healthcare, today announced that
it will be the clinical content source for patient [...]

Agendia and Ferrer inCode Expand MammaPrint(R) Distribution Agreement to Latin America

HUNTINGTON BEACH, California and AMSTERDAM, April 20, 2010 – Agendia, a world leader in molecular cancer diagnostics, announced today
it has closed an agreement with Ferrer inCode for the commercialization of
Agendia's FDA-cleared breast cancer recurrence test MammaPrint in Latin
America.

For the successful commercialization of MammaPrint, Ferrer inCode will
leverage the distribution power of [...]

Posit Science Disputes Results of the BBC Brain Training Study

Fatal Flaw in Methodology Provides Overly Generalized Findings
SAN FRANCISCO, April 20, 2010 – Posit Science (www.positscience.com), the leader in clinically
proven brain fitness programs, contests the interpretation and methodology
used in a British Broadcasting Corporation-sponsored study published in the
journal Nature.

Researchers in the BBC study found that their own cognitive training
programs, designed specifically [...]

SIRO Clinpharm Forms Alliance With VCRO, a Taiwan- based CRO

Pact enables SIRO's clients access to blooming Taiwan clinical research market

MUMBAI, India, April 21, 2010 – SIRO Clinpharm a Contract Research Organization (CRO) with a presence in
India, Western and Central Eastern Europe and the USA today announced its
alliance with Virginia Contract Research Organization Co., Ltd. (VCRO), a
Taiwan-based CRO.
VCRO has more [...]

MarketsandMarkets: Global Ophthalmology Devices Market 2009-2014 Worth US$16.2 Billion by 2014

DALLAS, Texas, April 21, 2010 – According to a new market research report, 'Global Ophthalmology Devices
Market (2009 – 2014), published by MarketsandMarkets (
www.marketsandmarkets.com), the total global ophthalmology devices
market is expected to be worth US$16.2 billion by 2014, and the U.S. market
will account for nearly 37.2% of the total revenues. The global IOL market
is expected [...]

Consider the ‘Whole-Man’ When Treating Prostate Cancer

Too Little Time Spent Discussing Emotional and Sexual Impact, Says New Survey

BARCELONA, April 21, 2010 – Health care professionals need to consider the impact of
prostate cancer on the 'whole man' rather than focusing on cancer treatment
in isolation, according to results from an international survey of prostate
cancer patients and their partners.
To [...]

Abbott Completes Acquisition of Facet Biotech

ABBOTT PARK, Illinois, April 21, 2010 – Abbott (NYSE: ABT) has completed its acquisition of Facet Biotech
Corporation, strengthening its pharmaceutical pipeline in immunology and
oncology.

The acquisition provides Abbott with a promising biologic intended to
treat multiple sclerosis (MS) and compounds that complement its existing
diverse oncology program. The new Abbott compounds include daclizumab [...]

The 5-HT3 Receptor Antagonist Aloxi(R) Launched in Japan

LUGANO, Switzerland and TOKYO, Japan, April 22, 2010 – Helsinn Healthcare SA, Switzerland, and Taiho Pharmaceutical Co., Ltd.,
Japanese licensee of Helsinn's second generation 5-HT3 receptor antagonist
palonosetron, announce the launch of Aloxi(R) injection today.

Aloxi was developed in Japan by Taiho in close cooperation
with Helsinn, based on the license agreement between Taiho [...]

Innovative Technology Could Transform Women’s Health Across Europe

Non-Invasive Treatment for Uterine Fibroids (Myoma) Given Special Recognition at the German Federal Chancellery

TIRAT CARMEL, Israel, April 22, 2010 – The ExAblate(R) 2000, a magnetic resonance guided focus ultrasound
system, received special recognition by being included in the 10th nationwide
Girls' Day in Germany. This event held on April 21st, 2010 at the German
Federal Chancellery, celebrates [...]

Celtic Pharma Announces Initiation of Pediatric Dose Tolerance Trial Evaluating XERECEPT(R) in Pediatric Patients with Primary and Metastatic Brain Tumors

NEW YORK, LONDON and HAMILTON, Bermuda, April 22, 2010 – Celtic Pharmaceutical Holdings L.P. ("Celtic Pharma") today announced the
initiation of a Phase I/II pediatric dose tolerance trial to test their
investigational new drug XERECEPT(R) in pediatric patients suffering from
primary, recurrent or metastatic brain tumors.

Celtic Pharma's objective for this trial is to [...]

Exeter(R) Hip System Celebrates 40th Anniversary and Manufacture of One-Millionth Hip Stem

Surgeon-Created Orthopaedic Hip System Revolutionized Hip Implant Design, Continues to Deliver Excellent Clinical Results

EXETER, England, April 22, 2010 – Stryker Corporation's Orthopaedics Division is celebrating this month the
one-millionth manufacturing of its Exeter hip stem (
www.exeterhip.co.uk), an implant developed in collaboration with an
orthopaedic surgeon and engineer to address the problem of aseptic loosening.
This year also [...]

El Instituto Palacios acogera en Espana a becarios de Master en Climaterio y Menopausia para potenciar su formacion en Salud de la Mujer

Master en Climaterio y Menopausia, un proyecto 100% online, cuenta con el respaldo de la FLASCYM, la IMS, el CAMS, la Asociacion Espanola para el Estudio de la Menopausia (AEEM) y los especialistas de mayor prestigio internacional

MADRID, April 22, 2010 – Master en Climaterio y Menopausia(R), una iniciativa que nace
con el objetivo de dar [...]

Amira Pharmaceuticals Announces Patent Grant in United Kingdom

Patent Covers Novel DP2 (CRTH2) Receptor Antagonists for the Treatment of Respiratory Disorders

SAN DIEGO, April 22, 2010 – Amira Pharmaceuticals, Inc. today announced that the U.K. Intellectual
Property Office has granted it patent number GB2460597
(www.ipo.gov.uk/p-find-publication-result?PatentNo=GB2460597&Journal
Number=0&EarliestYear=1900&EarliestWeek=1&LatestYear=2050&LatestWeek=52&Doc
Types=A%2CA8%2CA9%2CB%2CB8%2CC%2CC2%2CC3&ResultsPerPage=2&Start=0 ) titled
"N,N-Disubstituted aminoalkylBiPhenyl Antagonists OF Prostaglandin d2
RECEPTORS."
This is the first patent granted of a large estate [...]

Colorcon Acquires Pharmaceutical Excipient Company – NP Pharm

HARLEYSVILLE, Pennsylvania, April 22, 2010 – Colorcon, Inc. today announced the acquisition of the full-service
pharmaceutical excipient company, NP Pharm, a Division of Ethypharm. This
acquisition expands Colorcon's global excipient product offerings in the
pharmaceutical and nutritional markets.

The addition of NP Pharm SUGLETS(R) sugar spheres complements Colorcon's
SureSpheres(R) sugar spheres product line and barrier [...]